This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2025 Nov 1;48(11):1875-1877.

doi: 10.2337/dci25-0088.

The FLOW of Progress in Diabetic Kidney Disease: Semaglutide's Role in Combination Therapy

Rajiv Agarwal^{1

2}

Affiliations

PMID: 41115233
DOI: 10.2337/dci25-0088

Editorial

The FLOW of Progress in Diabetic Kidney Disease: Semaglutide's Role in Combination Therapy

Rajiv Agarwal. Diabetes Care. 2025.

. 2025 Nov 1;48(11):1875-1877.

doi: 10.2337/dci25-0088.

Author

Rajiv Agarwal^{1

2}

Affiliations

¹ Richard L. Roudebush VA Medical Center, Indianapolis, IN.
² Indiana University School of Medicine, Indianapolis, IN.

PMID: 41115233
DOI: 10.2337/dci25-0088

No abstract available

PubMed Disclaimer

Comment on

Effects of Semaglutide With or Without Concomitant Mineralocorticoid Receptor Antagonist Use in Participants With Type 2 Diabetes and Chronic Kidney Disease: A FLOW Trial Prespecified Secondary Analysis.
Rossing P, Bakris G, Perkovic V, Pratley R, Tuttle KR, Mahaffey KW, Idorn T, Belmar N, Bosch-Traberg H, Rasmussen S, Busch RS, Schmieder RE, Gillard P, Mann JFE; FLOW Investigator Group. Rossing P, et al. Diabetes Care. 2025 Nov 1;48(11):1878-1887. doi: 10.2337/dc25-0472. Diabetes Care. 2025. PMID: 40730031 Free PMC article. Clinical Trial.

Publication types

Actions
Actions

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems